Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C
✍ Scribed by H. Tanaka; M. Miyano; H. Ueda; K. Fukui; M. Ichinose
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 119 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0372-8722
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Hepatitis C virus (HCV), a positive stranded RNA virus, is the main causative agent of post‐transfusion and sporadic non‐A non‐B hepatitis worldwide. Paired samples of plasma and peripheral blood mononuclear cells (PBMC) from 11 patients with chronic hepatitis C treated with α‐interfero
## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca